18.02.2020

Frankfurt: Nitrosamine Impurities

In this conference you will get to know the relevant aspects of risk mitigation with respect to potential Nitrosamine contamination in drug substances and drug products. Dr. Hiltrud Horn will discuss what has to be considered for manufacturers and what are potential sources of Nitrosamines. You will also see a practical example of risk assessment.

For more information please visit the following website:
https://www.gmp-navigator.com/seminare/gmp-seminar-konferenz/nitrosamine-impurities

(Conference organized by Concept Heidelberg)



Back

HOTLINE

Phone +49 (0) 7251/305 529
Fax +49 (0) 7251/305 528
Mail

Events

  • 25.08.2020
    Online Seminar: Prozessvalidierung - Aktuelle Anforderungen an CMC-Daten
    More
  • 06.-07.10.2020
    Vienna: Change Control – New Aspects and Best Practices
    More
  • 08.-09.10.2020
    Vienna: ICH Q8 – Q11 Training Course
    More
Get all events



News

  • 18.05.2020
    Impact of COVID-19 pandemic on Pharma: GMP and Regulatory Flexibility
    More
  • 26.03.2020
    New Deadline for Nitrosamine Impurities
    More
  • 24.03.2020
    News on Nitrosamine Impurities
    More
Get all news
EU: New Variation System in force as of Jan 1, 2010. Filing of variations will be faster, easier, and more flexible. Have you considered that your Change Control System needs to be updated accordingly?
EU: Centralised Marketing Authorisation Procedure for ATMPs needed Have you already filed your application? The time clock is ticking. Transitional periods will be over soon.
This website uses cookies. By using the website you agree to the use of cookies. Privacy Policy X